Nasdaq:US$16.56 (+0.33) | HKEX:HK$26.90 (+0.85) | AIM:£2.50 (+0.06)
搜索
News & Press Releases
123456789101112131415161718
19
找到相关结果： 936
公告及新闻稿, 其他业务 | 2008-05-23

China Healthcare Division Chi-Med increases ownership of its Hutchison Healthcare joint venture
公告及新闻稿, 其他业务 | 2008-05-19

Expansion of Consumer Products division Sen launches in 125 Marionnaud beauty stores
公告及新闻稿, 监管通知 | 2008-05-09

Results of Annual General Meeting
公告及新闻稿, 监管通知 | 2008-04-22

Holding in Company
公告及新闻稿, 监管通知 | 2008-04-09

Annual Report 2007 and Notice of Annual General Meeting
公告及新闻稿, 监管通知 | 2008-03-31

Holding in Company
公告及新闻稿, 集团 | 2008-03-19

Preliminary Results for the year ended 31 December 2007
公告及新闻稿, 肿瘤学 / 免疫学 | 2008-02-29

Chi-Med Announces Start of Patient Enrolment in a Global Phase IIb Ulcerative Colitis Clinical Trial of HMPL-004, its Leading Anti-Inflammatory Drug Candidate
公告及新闻稿, 监管通知 | 2008-02-28

Notice of 2007 Preliminary Results
公告及新闻稿, 监管通知 | 2008-02-28

Change in the Registered Office Address in the Cayman Islands
公告及新闻稿, 其他业务 | 2008-01-21

Strong growth in China Healthcare divisionStreamlining of product range set to further improve financial performance
公告及新闻稿, 监管通知 | 2007-12-27

Block Admission Return
公告及新闻稿, 肿瘤学 / 免疫学 | 2007-11-22

Chi-Med Plans to Initiate Global Phase IIb Trials of its Lead Anti-Inflammatory Drug Candidate, HMPL-004, in Ulcerative Colitis Patients
公告及新闻稿, 肿瘤学 / 免疫学 | 2007-08-20

和黄医药与美国礼来签订新药研发战略合作协议
2007年9月18日，和黄医药与制药巨头美国礼来公司（简称“礼来”）于上海浦东金茂君悦酒店隆重召开合作庆典仪式，正式宣布双方在新药研发领域建立战略合作关系。这是中国药物研发历史
阅读更多
查看公告 (PDF)
公告及新闻稿, 集团 | 2007-08-09

Interim Results for the Six Months Ended 30 June 2007
公告及新闻稿, 监管通知 | 2007-07-18

Notice of Interim Results
公告及新闻稿, 肿瘤学 / 免疫学 | 2007-07-02

Chi-Med Announces Positive Phase II Proof-of-Concept Data for HMPL-004 in Ulcerative Colitis
公告及新闻稿, 监管通知 | 2007-06-22

Block Admission
公告及新闻稿, 肿瘤学 / 免疫学 | 2007-06-18

Chi-Med locks-in property gain and protects low cost R&D structure through acquisition of Shanghai facility
公告及新闻稿, 肿瘤学 / 免疫学 | 2007-05-23

Chi-Med completes patient enrolment on its HMPL-004 ulcerative colitis proof-of-concept; Phase II clinical trial in China
公告及新闻稿, 监管通知 | 2007-05-22

Director's Shareholding
公告及新闻稿, 监管通知 | 2007-05-11

Results of Annual General Meeting
公告及新闻稿, 监管通知 | 2007-04-12

Annual Report and Accounts 2006 - Notice of Annual General Meeting
公告及新闻稿, 监管通知 | 2007-04-02

Board Change
公告及新闻稿, 监管通知 | 2007-03-23

Director's Shareholding
公告及新闻稿, 集团 | 2007-03-21

Preliminary Results for the year ended 31 December 2006
公告及新闻稿, 监管通知 | 2007-02-26

Notice of Preliminary Results
公告及新闻稿, 其他业务 | 2007-01-17

Related party transaction Chi-Med formalises China Sales and Distribution Arrangements
公告及新闻稿, 监管通知 | 2007-01-05

Appointment of Joint Broker
公告及新闻稿, 肿瘤学 / 免疫学 | 2006-11-20

和黄医药与默克共同开发新型小分子抗癌药物
和黄医药与德国默克签署合作协议联合研究新型抗癌药物，双方将合作研究能够调节肿瘤信号通路的天然产物来源的小分子药物。 和黄中国医药科技有限公司CEO，Christian Hogg先生说： “
阅读更多
查看公告 (PDF)
公告及新闻稿, 肿瘤学 / 免疫学 | 2006-11-06

和黄医药与宝洁公司合作开展美容产品新活性成分研发
和黄医药与宝洁公司签署合作研发协议，与宝洁公司美容部合作从传统中药及植物资源中研究用于美容产品的新活性成分。 这项合作为期两年，和黄中国医药科技成员负责使用宝洁指定的
阅读更多
查看公告 (PDF)
公告及新闻稿, 监管通知 | 2006-09-29

Appointment of Senior Independent Director
公告及新闻稿, 集团 | 2006-08-09

Financial Results for the Six Months Ended 30 June 2006
公告及新闻稿, 监管通知 | 2006-07-26

Notice of Maiden Interim Results
公告及新闻稿, 集团 | 2006-07-17

Trading Update
公告及新闻稿, 肿瘤学 / 免疫学 | 2006-07-04

Chi-Med plans to broaden clinical trials of its leading oncology drug candidate
123456789101112131415161718
19